462 results on '"Woillard , Jean-Baptiste"'
Search Results
2. Synergizing pharmacometrics and pharmacovigilance for medication error management: the case of secukinumab
3. Optimization of Ganciclovir and Valganciclovir Starting Dose in Children by Machine Learning
4. Limited sampling strategy and population pharmacokinetic model of mycophenolic acid in pediatric patients with systemic lupus erythematosus: application of a double gamma absorption model with SAEM algorithm
5. Within-subject pharmacokinetic variability has a strong influence on individual exposure ratios in bioequivalence studies, hence on drug formulation interchangeability
6. Bridging the Worlds of Pharmacometrics and Machine Learning
7. In Silico Pharmacokinetics Evaluation of Forgiveness for Doravirine and Rilpivirine
8. Diagnostic, prognostic and clinical value of left ventricular radial strain to identify paradoxical septal motion in ventilated patients with the acute respiratory distress syndrome: an observational prospective multicenter study
9. In Silico Pharmacokinetics Evaluation of Forgiveness for Doravirine and Rilpivirine
10. A Hybrid Algorithm Combining Population Pharmacokinetic and Machine Learning for Isavuconazole Exposure Prediction
11. Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation
12. Optimization of Vancomycin Initial Dose in Term and Preterm Neonates by Machine Learning
13. A Hybrid Model Associating Population Pharmacokinetics with Machine Learning: A Case Study with Iohexol Clearance Estimation
14. Mycophenolate Mofetil Dose Adjustment in Pediatric Kidney Transplant Recipients
15. SAT-052 Artificial intelligence and liver transplantation: posttransplantation chronic kidney disease prediction
16. Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus
17. A Machine Learning Approach to Predict Interdose Vancomycin Exposure
18. Doravirine Exposure Decreased by Dialysis in a HIV Patient: A Grand Round
19. To be or not to be, when synthetic data meet clinical pharmacology: A focused study on pharmacogenetics.
20. Population Pharmacokinetics and Limited Sampling Strategy of Mycophenolate Mofetil for Indian Patients With Lupus Nephritis.
21. Population Pharmacokinetic of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.
22. Longitudinal Exposure to Tacrolimus and New-Onset Diabetes Mellitus in Renal Transplant Patients
23. Thoroughly Validated Bayesian Estimator and Limited Sampling Strategy for Dose Individualization of Ganciclovir and Valganciclovir in Pediatric Transplant Recipients
24. Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients
25. Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis
26. Synthèse des recommandations de l’International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) sur le suivi thérapeutique pharmacologique du tacrolimus
27. A Machine Learning Approach to Estimate the Glomerular Filtration Rate in Intensive Care Unit Patients Based on Plasma Iohexol Concentrations and Covariates
28. Evaluating Use of Artificial Intelligence for Drug Exposure and Effect Prediction
29. Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on everolimus blood exposure and clinical outcomes in cancer patients
30. Population pharmacokinetics of gentamicin in haemodialysis patients: modelling, simulations and recommendations
31. A donor and recipient candidate gene association study of allograft loss in renal transplant recipients receiving a tacrolimus-based regimen
32. Tacrolimus population pharmacokinetics in adult heart transplant patients
33. Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study
34. A Population Pharmacokinetic Modeling Approach to Determine the Efficacy of Intravenous Amikacin in Children with Cystic Fibrosis
35. Tacrolimus Bayesian dose adjustment in pediatric renal transplant recipients
36. Neurotoxicity Despite a Renal Function Adjusted Cefepime Regimen: A Case Study
37. Evaluation of a non-parametric modelling for meropenem in critically ill patients using Monte Carlo simulation
38. A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators
39. Pharmacogénétique des immunosuppresseurs : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx)
40. Pharmacogenetics of immunosuppressants: State of the art and clinical implementation – recommendations from the French National Network of Pharmacogenetics (RNPGx)
41. Phenotyping of Uracil and 5-Fluorouracil Metabolism Using LC-MS/MS for Prevention of Toxicity and Dose Adjustment of Fluoropyrimidines
42. A Method for Evaluating Robustness of Limited Sampling Strategies—Exemplified by Serum Iohexol Clearance for Determination of Measured Glomerular Filtration Rate
43. Association of the OPRM1 and COMT genes’ polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?
44. Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections
45. Therapeutic Drug Monitoring of Everolimus in Oncology: Evidences and Perspectives
46. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
47. Application of machine learning to predict tacrolimus exposure in liver and kidney transplant patients given the MeltDose formulation
48. Machine learning-supported interpretation of kidney graft elementary lesions in combination with clinical data
49. Vascular endothelial growth factor, tissue factor, coagulation and fibrinolysis markers in slow-flow vascular malformations: a prospective study of treatment with sirolimus
50. Can the Area Under the Curve/Trough Level Ratio Be Used to Optimize Tacrolimus Individual Dose Adjustment?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.